RT Journal Article
SR Electronic
A1 Lederman, Lynne
T1 Ergocalciferol Supplementation in Patients Undergoing Hemodialysis is Safe but without Benefit
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 14
IS 49
SP 11
OP 12
DO 10.1177/155989771449005
UL http://mdc.sagepub.com/content/14/49/11.abstract
AB Vitamin D deficiency has been linked to cardiovascular events and mortality, infection, and autoimmune disorders. Deficiency of 25-hydroxyvitamin D [25(OH)D] <30 ng/mL occurs in about 80% of patients undergoing dialysis. The double-blind, placebo-controlled Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients [NCT01395823] trial investigated the safety and effects of dosing on dialysis patients, as discussed in this article.